Abstract:Introduction National Comprehensive Cancer Network has recommended cryoablation to replace the resection in the treatment of medically operable non-small cell lung cancer (NSCLC). Cryoablation also has been used for the advanced NSCLC in randomised controlled trials. However, they have not been systematically reviewed. Here, we provide a protocol to evaluate the effectiveness and safety of cryoablation in the treatment of advanced NSCLC. Methods and analyses We will search PubMed, Embase, the Cochrane Library, Chinese Biomedical Database, China National Knowledge Infrastructure, Wanfang Database and Chinese Scientific Journal Database without language restrictions from inception until 1 February 2020. Trial registers (International Clinical Trials Registry platform, the US National Institutes of Health Ongoing Trials Register and the ISRCTN registry) and reference lists of retrieved articles will also be searched. Two reviewers will independently extract data on participants, interventions, comparisons, outcomes and assess the methodological quality by the Cochrane risk of bias tool. The strength of evidences will be evaluated according to the Grading of Recommendations Assessment, Development and Evaluation approach. Review Manager V.5.3 software will be used for data analyses. Meta-analyses will be performed if the data are sufficiently homogeneous. The primary outcomes will be objective response rate and overall survival. The secondary outcomes will be adverse effects, health-related quality of life, changes of immune indicators and surrogate outcomes (disease control rate, progression-free survival and survival rate). Ethics and dissemination Ethics approval is not required, as this study will not involve patients. The results of this study will be submitted to a peer-reviewed journal for publication, to inform both clinical practice and further research. PROSPERO registration number CRD42019138660.

Research Progress in Cryoablation Therapy for Breast Tumor

Research progress on anti-tumor immune effect of cryoablation

Progress in the cryoablation and cryoimmunotherapy for tumor

Modern cancer therapy: cryoablation meets immune checkpoint blockade

Cryotherapy in the Treatment of Early-Stage Breast Cancer

Status and Prospect of Cryosurgery for Lung Cancer

Research Advances of Anti-Tumor Immune Response Induced by Pulse Electric Field Ablation

Non-surgical ablation for breast cancer: an emerging therapeutic option

Nano Cryosurgical Therapy: New Frontier in Nano Medicine

Cryoablation and immune synergistic effect for lung cancer: A review

Thermal ablation in cancer

PD-1 monoclonal antibodies enhance the cryoablation-induced antitumor immune response: a breast cancer murine model research

Localized Relapse in Bone Marrow in a Posttransplantation Patient with t(6;9) Acute Myeloid Leukemia

Review and Evaluation on the Latest Advancement in Cryotherapy

Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy

Cryoablation for advanced non-small cell lung cancer: a protocol for a systematic review

Radiofrequency Heat-Enhanced Chemotherapy for Breast Cancer: Towards Interventional Molecular Image-Guided Chemotherapy.

Treatment Options for Early Stage Inoperable Breast Cancer: Cryoablation or Radiotherapy?

Evaluation of cryoablation therapy for lung cancer

Ablative Therapies for Breast Cancer: State of Art